Torrent Pharmaceuticals Limited has informed the Exchange about Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2022

�;orrent-W PHARmA

30th J1.ily, 2022

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., I st Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 00 I (BSE Scrip Code: 500420)

Dear Sir,

The Manager - Listing Dept., National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051 (NSE Scrip Code: TORNTPHARM)

Sub.: Audio Recording of Conference call with Analysts/ Investors on Financial Results for

the quarter ended 30th June, 2022

. In continuation of our letter dated 2 I-Jul-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter ended 30th June, 2022, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/ Audio Recording30062022.mp3

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED

MAHESH AGRAWAL

p (LEGAL) & COMPANY SECRETARY

�

Reg.Office : Torrent House, Off Ashram Road, Ahmedabad - 380 009, India. Phone: +91 79 26599000, Fax : +91 79 26582100, www.torrentpharma.com

.

TORRENT PHARMACEUTICALS LIMITED CIN : L24230GJ1972PLC002126